The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies
- DOI
- 10.1186/s43046-026-00389-0
- Published
- 2026-07-27
- Container
- Journal of the Egyptian National Cancer Institute
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s43046-026-00389-0,
title = {The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies},
author = {Dwi Faradina and Muhammad Rusda and Muhammad Fidel Ganis Siregar and Cut Adeya Adella and Agung Putra and Arya Tjipta Prananda and Dodi Suardi and Johny Marpaung and Felix Khosasi},
year = {2026},
journal = {Journal of the Egyptian National Cancer Institute},
doi = {10.1186/s43046-026-00389-0},
url = {https://doi.org/10.1186/s43046-026-00389-0}
}RIS
TY - JOUR TI - The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies AU - Dwi Faradina AU - Muhammad Rusda AU - Muhammad Fidel Ganis Siregar AU - Cut Adeya Adella AU - Agung Putra AU - Arya Tjipta Prananda AU - Dodi Suardi AU - Johny Marpaung AU - Felix Khosasi PY - 2026 JO - Journal of the Egyptian National Cancer Institute DO - 10.1186/s43046-026-00389-0 UR - https://doi.org/10.1186/s43046-026-00389-0 ER -
APA
Faradina, D., Rusda, M., Siregar, M. F. G., Adella, C. A., Putra, A., Prananda, A. T., Suardi, D., Marpaung, J., & Khosasi, F. (2026). The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1186/s43046-026-00389-0
Source records
- crossref · retrieved 2026-11-05T01:33:51.785Z